e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Assessing the relevance of obstructive airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum
C. R. Chittleborough, A. W. Taylor, D. H. Wilson, R. J. Adams, R. E. Ruffin (Adelaide, Australia)
Source:
Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Session:
Assessing the relevance of obstructive airway diseases
Session type:
Oral Presentation
Number:
3073
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. R. Chittleborough, A. W. Taylor, D. H. Wilson, R. J. Adams, R. E. Ruffin (Adelaide, Australia). Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum. Eur Respir J 2005; 26: Suppl. 49, 3073
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Evidence for the onset of COPD in childhood, and the role of genetics
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005
Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Regional ventilatory defects in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
Population impact of different definitions of airway obstruction
Source: Eur Respir J 2003; 22: 268-273
Year: 2003
Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013
Why is there often discordance between cross sectional and longitudinal studies of dust-induced COPD?
Source: Annual Congress 2005 - Better understanding of lung function decline and COPD
Year: 2005
Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV
1
) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007
A new multidimensional model for predicting mortality in COPD: body mass index and FEV1 quotient/MRC dyspnoea score (SID)
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006
Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Hoover‘s sign predicts expiratory flow limitation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 807s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept